These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2358 related articles for article (PubMed ID: 11435833)
1. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer. Noguchi M; Stamey TA; McNeal JE; Yemoto CM J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833 [TBL] [Abstract][Full Text] [Related]
2. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340 [TBL] [Abstract][Full Text] [Related]
3. Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ-confined disease. Miyake H; Sakai I; Harada K; Hara I; Eto H Int J Urol; 2005 Mar; 12(3):270-4. PubMed ID: 15828954 [TBL] [Abstract][Full Text] [Related]
4. Prostate needle biopsies: multiple variables are predictive of final tumor volume in radical prostatectomy specimens. Poulos CK; Daggy JK; Cheng L Cancer; 2004 Aug; 101(3):527-32. PubMed ID: 15274065 [TBL] [Abstract][Full Text] [Related]
5. The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management. Ochiai A; Troncoso P; Chen ME; Lloreta J; Babaian RJ J Urol; 2005 Dec; 174(6):2164-8, discussion 2168. PubMed ID: 16280756 [TBL] [Abstract][Full Text] [Related]
6. The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis. Cupp MR; Bostwick DG; Myers RP; Oesterling JE J Urol; 1995 May; 153(5):1543-8. PubMed ID: 7714976 [TBL] [Abstract][Full Text] [Related]
7. The independent impact of extended pattern biopsy on prostate cancer stage migration. Master VA; Chi T; Simko JP; Weinberg V; Carroll PR J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288 [TBL] [Abstract][Full Text] [Related]
8. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features. Boccon-Gibod LM; Dumonceau O; Toublanc M; Ravery V; Boccon-Gibod LA Eur Urol; 2005 Dec; 48(6):895-9. PubMed ID: 16125298 [TBL] [Abstract][Full Text] [Related]
9. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy. Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061 [TBL] [Abstract][Full Text] [Related]
10. Preoperative prediction of small volume cancer (less than 0.5 ml) in radical prostatectomy specimens. Cheng L; Poulos CK; Pan CX; Jones TD; Daggy JK; Eble JN; Koch MO J Urol; 2005 Sep; 174(3):898-902. PubMed ID: 16093983 [TBL] [Abstract][Full Text] [Related]
11. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors. Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301 [TBL] [Abstract][Full Text] [Related]
12. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database. Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC; J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735 [TBL] [Abstract][Full Text] [Related]
13. The significance of prior benign needle biopsies in men subsequently diagnosed with prostate cancer. Epstein JI; Walsh PC; Akingba G; Carter HB J Urol; 1999 Nov; 162(5):1649-52. PubMed ID: 10524890 [TBL] [Abstract][Full Text] [Related]
14. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively? Rubin MA; Mucci NR; Manley S; Sanda M; Cushenberry E; Strawderman M; Montie JE; Bassily NH J Urol; 2001 Jan; 165(1):114-8. PubMed ID: 11125378 [TBL] [Abstract][Full Text] [Related]
15. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068 [TBL] [Abstract][Full Text] [Related]
16. One core positive prostate biopsy is a poor predictor of cancer volume in the radical prostatectomy specimen. Wang X; Brannigan RE; Rademaker AW; McVary KT; Oyasu R J Urol; 1997 Oct; 158(4):1431-5. PubMed ID: 9302137 [TBL] [Abstract][Full Text] [Related]
17. Prediction of pathological stages before prostatectomy in prostate cancer patients: analysis of 12 systematic prostate needle biopsy specimens. Park EA; Lee HJ; Kim KG; Kim SH; Lee SE; Choe GY Int J Urol; 2007 Aug; 14(8):704-8. PubMed ID: 17681059 [TBL] [Abstract][Full Text] [Related]
18. Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population? Anast JW; Andriole GL; Bismar TA; Yan Y; Humphrey PA Urology; 2004 Sep; 64(3):544-50. PubMed ID: 15351590 [TBL] [Abstract][Full Text] [Related]
19. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Divrik RT; Eroglu A; Sahin A; Zorlu F; Ozen H Urol Oncol; 2007; 25(5):376-82. PubMed ID: 17826653 [TBL] [Abstract][Full Text] [Related]
20. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers. Noguchi M; Stamey TA; McNeal JE; Yemoto CM J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]